The identification of circulating IFN-γ and IL-4-producing RD1-specific T cells ex vivo, as measured in the ELISPOT assay, indicate a recent encounter with antigen from Mtb in vivo and their overall frequencies may be directly related to bacterial load in patients undergoing treatment for pulmonary TB. Here, IL4 is linked to pulmonary tuberculosis.